Literature DB >> 22931916

Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota.

Benjamin G Vazquez1, Ali Alikhan, Amy L Weaver, David A Wetter, Mark D Davis.   

Abstract

There are no population-based incidence studies of hidradenitis suppurativa (HS). Using the medical record linkage system of the Rochester Epidemiology Project, we sought to determine the incidence of the disease, as well as other associations and characteristics, among HS patients diagnosed in Olmsted County, Minnesota, between 1968 and 2008. Incidence was estimated using the decennial census data for the county. Logistic regression models were fit to evaluate associations between patient characteristics and disease severity. A total of 268 incident cases were identified, with an overall annual age- and sex-adjusted incidence of 6.0 per 100,000. Age-adjusted incidence was significantly higher in women compared with men (8.2 (95% confidence interval (CI), 7.0-9.3) vs. 3.8 (95% CI, 3.0-4.7). The highest incidence was among young women aged 20-29 years (18.4 per 100,000). The incidence has risen over the past four decades, particularly among women. Women were more likely to have axillary and upper anterior torso involvement, whereas men were more likely to have perineal or perianal disease. In addition, 54.9% (140/255) patients were obese; 70.2% were current or former smokers; 42.9% carried a diagnosis of depression; 36.2% carried a diagnosis of acne; and 6% had pilonidal disease. Smoking and gender were significantly associated with more severe disease.

Entities:  

Mesh:

Year:  2012        PMID: 22931916      PMCID: PMC3541436          DOI: 10.1038/jid.2012.255

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  21 in total

1.  Perianal hidradenitis suppurativa; a clinical and pathologic study.

Authors:  M J ANDERSON; M B DOCKERTY
Journal:  Dis Colon Rectum       Date:  1958 Jan-Feb       Impact factor: 4.585

Review 2.  Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases.

Authors:  Hilal Maradit Kremers; Cynthia S Crowson; Sherine E Gabriel
Journal:  Rheum Dis Clin North Am       Date:  2004-11       Impact factor: 2.670

3.  Cigarette smoking as a triggering factor of hidradenitis suppurativa.

Authors:  A König; C Lehmann; R Rompel; R Happle
Journal:  Dermatology       Date:  1999       Impact factor: 5.366

4.  Yield from a complete skin examination. Findings in 1157 new dermatology patients.

Authors:  D P Lookingbill
Journal:  J Am Acad Dermatol       Date:  1988-01       Impact factor: 11.527

5.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

6.  Evidence of genetic factors in hidradenitis suppurativa.

Authors:  J S Fitzsimmons; P R Guilbert; E M Fitzsimmons
Journal:  Br J Dermatol       Date:  1985-07       Impact factor: 9.302

7.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

8.  The prevalence of hidradenitis suppurativa and its potential precursor lesions.

Authors:  G B Jemec; M Heidenheim; N H Nielsen
Journal:  J Am Acad Dermatol       Date:  1996-08       Impact factor: 11.527

9.  Psychosocial impact of hidradenitis suppurativa: a qualitative study.

Authors:  Solveig Esmann; Gregor B E Jemec
Journal:  Acta Derm Venereol       Date:  2011-05       Impact factor: 4.437

10.  The symptomatology of hidradenitis suppurativa in women.

Authors:  G B Jemec
Journal:  Br J Dermatol       Date:  1988-09       Impact factor: 9.302

View more
  73 in total

Review 1.  Hidradenitis Suppurativa: Causes, Features, and Current Treatments.

Authors:  Caroline Vinkel; Simon Francis Thomsen
Journal:  J Clin Aesthet Dermatol       Date:  2018-10-01

2.  Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group.

Authors:  Isabel Greco Tavora; Gabriela Cabral Bissoli; Hélio Amante Miot; Juliano Vilaverde Schmitt
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

3.  Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.

Authors:  Peter Theut Riis; Ditte Marie Saunte; Viktoria Sigsgaard; Axel Patrice Villani; Philippe Guillem; José C Pascual; Naomi N Kappe; Annika M J D Vanlaerhoven; Hessel H van der Zee; Errol P Prens; Moetaz El-Domyati; Hossam Abdel-Wahab; Nayera Moftah; Rania Abdelghani; Eugenia Agut-Busquet; Jorge Romaní; Carol Hlela; Lerinza van den Worm; Vincenzo Bettoli; Giada Calamo; Mehmet Ali Gürer; Burcu Beksaç; Lukasz Matusiak; Amelia Glowaczewska; Jacek C Szepietowski; Lennart Emtestam; Jan Lapins; Hassan Riad Kottb; Mohammad Fatani; Lisa Weibel; Martin Theiler; Maïa Delage-Toriel; Thi Thanh Hong Lam; Aude Nassif; Pierre-Andre Becherel; Mateja Dolenc-Voljc; Nejib Doss; Dorra Bouazzi; Farida Benhadou; Veronique Del Marmol; Gregor B E Jemec
Journal:  Arch Dermatol Res       Date:  2020-03-12       Impact factor: 3.017

Review 4.  [Hidradenitis suppurativa/acne inversa: An update].

Authors:  J Kirschke; S Hessam; F G Bechara
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

5.  Interferon-gamma (IFN-γ) is Elevated in Wound Exudate from Hidradenitis Suppurativa.

Authors:  Anirban Banerjee; Sean McNish; Victoria K Shanmugam
Journal:  Immunol Invest       Date:  2016-11-07       Impact factor: 3.657

6.  The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials.

Authors:  J S Kirby; L Thorlacius; B Villumsen; J R Ingram; A Garg; K B Christensen; M Butt; S Esmann; J Tan; G B E Jemec
Journal:  Br J Dermatol       Date:  2019-12-26       Impact factor: 9.302

Review 7.  Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.

Authors:  Nicolò Scuderi; Ambra Monfrecola; Luca Andrea Dessy; Gabriella Fabbrocini; Matteo Megna; Giuseppe Monfrecola
Journal:  Skin Appendage Disord       Date:  2017-03-21

8.  Characteristics of inflammatory eye disease associated with hidradenitis suppurativa.

Authors:  Didem Saygın; Abrahim U Syed; Careen Y Lowder; Sunil Srivastava; Juan J Maya; Rula A Hajj-Ali
Journal:  Eur J Rheumatol       Date:  2018-06-22

9.  The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.

Authors:  George Denny; Milan J Anadkat
Journal:  J Am Acad Dermatol       Date:  2016-09-28       Impact factor: 11.527

Review 10.  The epidemiology of skin and skin-related diseases: a review of population-based studies performed by using the Rochester Epidemiology Project.

Authors:  Louise K Andersen; Mark D P Davis
Journal:  Mayo Clin Proc       Date:  2013-12       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.